CD4 and neoplasm: HMGB1 can activate TLR2 and TLR4 on dendritic cells (DCs) to initiate antigen presentation and cytokine secretion, activating antigen‐specific CD4+ T cells and CD8+ T cells to recognize and eradicate tumor cells.